Initial analysis of the synergy of programmed cell death-1 (PD-1) inhibitor and concurrent chemoradiotherapy treatment for recurrent/metastatic head and neck squamous cell carcinoma patients.

Radiat Oncol · 2023 · PMC10318764 · PMID 37403098

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

Keynote 412 study showed there was a favorable trend toward improved EFS in all the population, and improved OS for patients with CPS≧20, however there was still no significant difference.

also in 993 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.